Episode
LTR 152: Omar Al Kalaa on Telesurgery and the Future of Remotely Controlled Medical Systems
- Podcast
- Let's Talk Risk! Podcast
- Published
- Apr 24, 2026
- Duration seconds
- 2181
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/let-s-talk-risk-podcast-6693844/episodes/ltr-152-omar-al-kalaa-on-telesurgery-and-the-future-of-remotely-controlled-medical-systems/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/let-s-talk-risk-podcast-6693844/ltr-152-omar-al-kalaa-on-telesurgery-and-the-future-of-remotely-controlled-medical-systems.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Summary “FDA is still asking the same core question here: can the sponsor demonstrate that the full system is safe and effective for the patient?” In this episode of the Let’s Talk Risk Podcast , host Naveen Agarwal sits down with Dr. Omar Al Kalaa to talk about one of the most important emerging frontiers in MedTech: remotely controlled medical systems. From telesurgery to connected infusion therapy, these technologies are expanding what is possible in patient care—but they also introduce a very different kind of system risk. Omar brings a rare perspective at the intersection of medical devices and telecommunications. We explore why the real issue is not just connectivity, but control; why access to care is a major driver of these technologies; and why companies entering this space must think beyond the device itself to the broader ecosystem of networks, partners, responsibilities, and safeguards. Chapters 00:00 – Introduction 01:56 – What “remote control” really means in MedTech 04:36 – Telesurgery vs. interoperable connected care systems 08:30 – Why access to healthcare is driving adoption 11:31 – Connectivity failure modes and misunderstood telecom concepts 13:47 – What fail-safe means in a telesurgery environment 18:24 – Risk ownership, contracts, and service level agreements 22:01 – How sponsors should think about FDA for novel connected systems 30:13 – Practical advice for engaging FDA in a stressed environment 32:35 – Why partnership, not silos, will shape the future of this field If you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter . Suggested links: * LTR: Wireless coexistence and risk in connected medical devices . * LTR: A new paradigm for building connected medical devices. * Advent Health News: Historic telesurgery connects…